Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peroxiredoxin 5 expression in the human thyroid gland.

A-C Gérard1, M-C Many, Ch Daumerie

  • 1Unité de Morphologie Expérimentale, B-1200, Bruxelles, Belgium.

Thyroid : Official Journal of the American Thyroid Association
|March 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involvement of mTOR and Regulation by AMPK in Early Iodine Deficiency-Induced Thyroid Microvascular Activation.

Endocrinology·2016
Same author

Involvement of nitric oxide in iodine deficiency-induced microvascular remodeling in the thyroid gland: role of nitric oxide synthase 3 and ryanodine receptors.

Endocrinology·2014
Same author

Switching from premixed insulin to basal-bolus insulin glargine plus rapid-acting insulin: the ATLANTIC study.

Acta clinica Belgica·2013
Same author

Axonal regeneration after peripheral nerve grafting and fibrin-fibronectin-containing matrix implantation on the injured septohippocampal pathway of the adult rat: a light and electron microscopic study.

Restorative neurology and neuroscience·2011
Same author

The thyroid angiofollicular units, a biological model of functional and morphological integration.

Bulletin et memoires de l'Academie royale de medecine de Belgique·2011
Same author

Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis.

European respiratory review : an official journal of the European Respiratory Society·2010

Peroxiredoxin 5 (PRDX5), an antioxidant enzyme, is expressed in the human thyroid. Its expression increases with thyroid cell activity, particularly in Graves' disease, suggesting a role in thyroid antioxidant defense.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • Peroxiredoxin 5 (PRDX5) is a thioredoxin peroxidase involved in antioxidant defense by reducing peroxides.
  • Understanding PRDX5 expression in the thyroid gland is crucial for elucidating its role in thyroid physiology and pathology.

Purpose of the Study:

  • To investigate the expression and localization of PRDX5 in normal and diseased human thyroid tissues.
  • To compare PRDX5 expression levels in different thyroid conditions, including multinodular goiters and Graves' disease.

Main Methods:

  • Immunohistochemistry was used to examine PRDX5 expression in 27 human thyroid specimens.
  • Immunoblotting was performed to quantify PRDX5 levels in multinodular goiters and Graves' disease tissues.

Related Experiment Videos

Main Results:

  • PRDX5 expression was observed in the cytoplasm and occasionally mitochondria of thyroid follicular cells, varying with cell activity.
  • PRDX5 labeling was enhanced in multinodular goiters and Graves' disease tissues compared to normal thyroid tissue.
  • PRDX5 expression levels were significantly higher in Graves' disease tissues than in multinodular goiters.

Conclusions:

  • PRDX5 is expressed in the human thyroid and likely functions as an antioxidant.
  • PRDX5 expression correlates with the functional status of thyroid epithelial cells, increasing in hyperthyroid conditions like Graves' disease.